Literature DB >> 19569174

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005.

N Le Stang1, A Belot, A Gilg Soit Ilg, P Rolland, P Astoul, S Bara, P Brochard, A Danzon, P Delafosse, P Grosclaude, A-V Guizard, E Imbernon, B Lapôtre-Ledoux, K Ligier, F Molinié, J-C Pairon, E-A Sauleau, B Trétarre, M Velten, N Bossard, M Goldberg, G Launoy, F Galateau-Sallé.   

Abstract

The evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005 was analysed using data derived from the French network of cancer registries (FRANCIM) and the French National Mesothelioma Surveillance Program (PNSM). Mesothelioma proportions in pleural cancers were calculated by diagnosis year in the 1980-2000 period. Our results suggest that the incidences of pleural cancer and mesothelioma levelled off in French men since 2000 and continued to increase in French women. A decrease of the annual pleural cancer incidence average in men was noticed (-3.4% of annual rate of change) between 2000 and 2005. The proportion of pleural cancers that were mesothelioma was unchanged between 1980 and 2003 with an average of 86%. The age standardised incidence rate of pleural mesothelioma remained relatively stable between 1998 and 2005 with a slight falling trend. For women, the age standardised incidence rate of pleural cancers and mesothelioma increased during the period 1998-2005. Additionally, the proportion of pleural cancers that were mesothelioma increased during the same period of time. Finally, the increased trend observed in the incidence of pleural mesothelioma and cancers in women is credibly due to their under diagnosis in the 1980-1997 period. The comparison between the French incidence and the American and British ones shows that the decreasing trend in incidence of mesothelioma and pleural cancers in French men since 2000 is potentially associated with a lower amphibole consumption and by the implementation of safety regulations at work from 1977.

Entities:  

Mesh:

Year:  2010        PMID: 19569174     DOI: 10.1002/ijc.24711

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.

Authors:  Vanya Delgermaa; Ken Takahashi; Eun-Kee Park; Giang Vinh Le; Toshiyuki Hara; Tom Sorahan
Journal:  Bull World Health Organ       Date:  2011-06-13       Impact factor: 9.408

2.  Pleural mesothelioma surveillance: validity of cases from a tumour registry.

Authors:  France Labrèche; Bruce W Case; Gaston Ostiguy; Jean Chalaoui; Michel Camus; Jack Siemiatycki
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

3.  Pleural and peritoneal mesotheliomas in the Friuli Venezia Giulia register: data analysis from 1995 to 2015 in Northeastern Italy.

Authors:  Flavia D'Agostin; Paola De Michieli; Carolin Chermaz; Corrado Negro
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  Mesothelioma incidence surveillance systems and claims for workers' compensation. Epidemiological evidence and prospects for an integrated framework.

Authors:  Alessandro Marinaccio; Alberto Scarselli; Enzo Merler; Sergio Iavicoli
Journal:  BMC Public Health       Date:  2012-07-05       Impact factor: 3.295

5.  Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients.

Authors:  C J Jennings; B Murer; A O'Grady; L M Hearn; B J Harvey; E W Kay; W Thomas
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.